Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The problem of pressure elevation associated with intravitreal triamcinolone.

× No keyword cloud information.

42 in total

1. Photodynamic therapy and intravitreal triamcinolone for a subretinal neovascularization in bilateral idiopathic juxtafoveal telangiectasis.

Authors: Lindsay M Smithen; Richard F Spaide
Journal: Am J Ophthalmol Date: 2004-11 Impact factor: 5.258

2. Intravitreal triamcinolone acetonide and intraocular pressure.

Authors: Lindsay M Smithen; Michael D Ober; Leandro Maranan; Richard F Spaide
Journal: Am J Ophthalmol Date: 2004-11 Impact factor: 5.258

3. Intraocular pressure elevation after intravitreal triamcinolone acetonide injection.

Authors: Hye Young Park; Kayoung Yi; Ha Kyoung Kim
Journal: Korean J Ophthalmol Date: 2005-06

Review 4. Intravitreal triamcinolone acetonide for treatment of intraocular proliferative, exudative, and neovascular diseases.

Authors: Jost B Jonas; Ingrid Kreissig; Robert Degenring
Journal: Prog Retin Eye Res Date: 2005-03-29 Impact factor: 21.198

5. Corticosteroids as an antiangiogenic agent for histoplasmosis-related subfoveal choroidal neovascularization.

Authors: A Martidis; D G Miller; T A Ciulla; R P Danis; R S Moorthy
Journal: J Ocul Pharmacol Ther Date: 1999-10 Impact factor: 2.671

6. Intraocular pressure elevation after intravitreal triamcinolone acetonide injection.

Authors: Jost B Jonas; Robert F Degenring; Ingrid Kreissig; Imren Akkoyun; Bernd A Kamppeter
Journal: Ophthalmology Date: 2005-04 Impact factor: 12.079

7. Inhibition of preretinal and optic nerve head neovascularization in pigs by intravitreal triamcinolone acetonide.

Authors: R P Danis; D P Bingaman; Y Yang; B Ladd
Journal: Ophthalmology Date: 1996-12 Impact factor: 12.079

8. Dosage dependency of intravitreal triamcinolone acetonide as treatment for diabetic macular oedema.

Authors: U H M Spandau; M Derse; P Schmitz-Valckenberg; C Papoulis; J B Jonas
Journal: Br J Ophthalmol Date: 2005-08 Impact factor: 4.638

9. The lack of toxicity of intravitreally administered triamcinolone acetonide.

Authors: B W McCuen; M Bessler; Y Tano; D Chandler; R Machemer
Journal: Am J Ophthalmol Date: 1981-06 Impact factor: 5.258

10. Exudative macular degeneration and intravitreal triamcinolone: 18 month follow up.

Authors: J K Challa; M C Gillies; P L Penfold; J F Gyory; A B Hunyor; F A Billson
Journal: Aust N Z J Ophthalmol Date: 1998-11